ano-ther8 hours ago
The more sober announcement from FDA: https://www.fda.gov/safety/recalls-market-withdrawals-safety...
They printed the wrong strength on packages.
> Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling